Cabotegravir
54 interactions 20 cited referencesCabotegravir is used along with rilpivirine (Edurant) as a short-term treatment of human immunodeficiency virus type 1 (HIV-1) infection in certain adults and adolescents 12 years of age or older weighing at least 77 pounds (35 kg). Cabotegravir is used as a short-term prevention of human immunodeficiency virus type 1… Read the full Cabotegravir drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Cabotegravir Tebipenem Pivoxil Increased tebipenem pivoxil exposure and an increased risk of tebipenem pivoxil-related adverse effects Details Cabotegravir Tenofovir Loss of virologic response and possible development of viral resistance Details Cabotegravir Tipranavir Aptivus Loss of virologic response and possible development of viral resistance Details Cabotegravir Zalcitabine Loss of virologic response and possible development of viral resistance Details Cabotegravir Zidovudine Retrovir Loss of virologic response and possible development of viral resistance Details Cabotegravir Enfuvirtide Injection Fuzeon Loss of virologic response and possible development of viral resistance Details Cabotegravir Ibalizumab-Uiyk Injection Trogarzo Loss of virologic response and possible development of viral resistance DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist